Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
THO complex subunit 7 (THOC7) is a 23 kDa nuclear protein that forms part of the THO complex, itself a core component of the larger TREX complex critical for mRNA biogenesis. The THO complex couples mRNA transcription, processing, and export processes, mostly by associating with fully spliced mRNAs. THOC7 plays an essential structural role in oligomerizing the complex; for example, it forms a coiled coil with THOC5, necessary for the assembly and stability of larger TREX structures in human cells. THOC7 is also implicated in the regulation of immune signaling, by negatively regulating type I interferon production through promotion of TBK1 degradation. Disruption or mutation of THOC7 or associated THO complex members can result in genetic syndromes or affect mRNA export, with downstream effects on cellular fitness and disease, including roles in viral infection and rare syndromic developmental disorders. To date, THOC7 is not a direct drug target, nor is it used as a biomarker in clinical practice.
Not applicable (no known drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on THO complex subunit 7 (THOC7).